Protembis GmbH Alternatives & Competitors

12 companies similar to Protembis GmbH — Full Cerebral Embolic Protection System to Reduce the Risk of Cerebrovascular Ev...

Transverse Medical Inc

Point-Guard Protected™ Stroke Matters. Safeguard the Brain, Treat the Heart.

10 Venture round $6.63M

Denver, United States

Biotechnology Health Care +2

Emboline, Inc.

21 Series D $80.00M

Santa Cruz, United States

Health Care Medical Devices +1

Claret Medical

Pioneering cerebral protection for safer vascular procedures.

Series C $41.22M

Health Care Medical Devices

HighLife

Trans-septal Mitral Valve Replacement

84 Series C $48.30M

Paris, France

Health Care Medical Devices

Rival Readout

Competing with Protembis GmbH? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Append Medical

Append Medical develops the next generation transcatheter Left Atrial Appendage (LAA) elim...

22 Series A $11.75M

Israel

Biotechnology Digital Health +2

Pi-Cardia

Leading the way for leaflet modification

59 Debt Financing $58.00M

Rehovot, Israel

Health Care Medical Devices

Filterlex Medical Ltd.

Full-body embolic protection for TAVR

9 Venture round $19.07M

Caesarea, Israel

Health Care Medical Devices

AMT Medical

The future of bypass surgery

42 Grant $2.50M

Ede, The Netherlands

Health Care Medical Devices

Novostia

Heart valves for life, for patients of any age, including children

15 $20.23M

Switzerland

Health Care Medical Devices

Embrella Cardiovascular

Developing advanced systems to enhance cerebral protection and minimize embolic strokes du...

Series B $9.00M

Health Care Medical Devices

JenaValve Technology, Inc.

Aortic regurgitation is different. So is our valve.

149 Series C $337.88M

Irvine, United States

Health Care Manufacturing +1

CoreValve

Pioneering non-surgical heart valve replacement with breakthrough catheter-based technolog...

Series C $77.00M

Health Care Health and Wellness

About Protembis GmbH

Protembis GmbH, established in 2013, is a pioneering medical device startup headquartered in Aachen, Germany. It is at the forefront of developing a revolutionary catheter-based filter device specifically designed to offer Full Cerebral Embolic Protection during cardiac interventions such as transcatheter aortic valve...

Services

development of cerebral protection systems, conducting clinical trials, research and development in cardiology

Target Customers

patients undergoing TAVR procedures, cardiologists, healthcare institutions

Business keywords

Cardiovascular Devices, Transcatheter Aortic Valve Replacement, Stroke Prevention, Cerebral Embolic Protection, Catheter-Based Filter, Neurological Safety, Interventional Cardiology, Clinical Studies, Heart Health Innovation, Minimally Invasive Procedures, Patient Safety Enhancement, Heart Valve Procedures, Medical Device Startups

Business Model

B2B

Revenue Model

Product Sales, One Time Purchase, Tiered Pricing

Frequently Asked Questions

Companies similar to Protembis GmbH include Transverse Medical Inc, Emboline, Inc., Claret Medical, HighLife, Append Medical. They work in Health Care and Medical Devices and share Protembis GmbH's focus on stroke prevention, interventional cardiology and cerebral embolic protection.

Bounce Watch lists 12 companies that share Protembis GmbH's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Protembis GmbH: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Protembis GmbH Profile Transverse Medical Inc Alternatives Emboline, Inc. Alternatives Claret Medical Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Protembis GmbH on 28 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 21 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.